Antifibrotic Effects of an α7 Nicotinic Acetylcholine Receptor Agonist in Keloid Fibroblasts and a Rat Scar Model. [PDF]
Roh H, Kim YH, Heo KJ, Hong JW, Lee WJ.
europepmc +1 more source
AGONIST-INDUCED AFFINITY ALTERATIONS OF A CENTRAL NERVOUS SYSTEM NICOTINIC ACETYLCHOLINE RECEPTOR
Ronald J Lukasiewicz, Edward L Bennett
openalex +1 more source
Effects of NPY and the specific Y1 receptor agonist [d-His26]-NPY on the deficit in brain reward function and somatic signs associated with nicotine withdrawal in rats [PDF]
Daria Rylkova +5 more
openalex +1 more source
Rational Use of Bethanechol in Dogs and Cats with Bladder Dysfunction. [PDF]
Galluzzi F +4 more
europepmc +1 more source
Agonist-induced hump current production in heterologously-expressed human α4β2-nicotinic acetylcholine receptors [PDF]
Qiang Liu +4 more
openalex +1 more source
Activation of the α7 nicotinic acetylcholine receptor mitigates cognitive deficits in mice with sepsis-associated encephalopathy by inhibiting microglial pyroptosis. [PDF]
Wang Q +7 more
europepmc +1 more source
HSV1 glycoprotein D utilizes an LY6-like binding domain to inhibit alpha7 nicotinic receptors. [PDF]
Yeasmin S +8 more
europepmc +1 more source
P4‐360: Improved cognition in Alzheimer's disease with a partial nicotinic agonist as assessed with cogtest [PDF]
Susan De Santi +2 more
openalex +1 more source
The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline
Jonathan Foulds
openalex +1 more source

